MSB 1.52% $1.01 mesoblast limited

Post-FDA approval - example gains of up to 1100% post-approval

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    ( all charts from https://www.mauldineconomics.com/ )

    Vanda Pharmaceuticals wins drug approval, stock soars

    https://www.bizjournals.com/washington/stories/2009/05/04/daily67.html

    Vanda Pharmaceuticals Inc. CEO Mihael Polymeropoulos described his emotional reaction to the e-mail attachment from the Food and Drug Administration late Wednesday evening in one word: relief.

    No doubt an understandable response to the FDA’s unforeseeable turnaround this week to greenlight Vanda’s lead drug, iloperidone, as a marketable schizophrenia treatment — less than nine months after the agency rejected it as being unapprovable.



    Screen Shot 2020-09-30 at 10.05.47 pm.png


    Atossa Genetics (ATOS) Reports FDA Approval of Oral Endoxifen for 'Expanded Access' as Post-Mastectomy Treatment for a U.S. Breast Cancer Patient

    https://www.streetinsider.com/Corpo...or a U.S. Breast Cancer Patient/15256553.html


    Screen Shot 2020-09-30 at 10.13.33 pm.png


    Sarepta Wins Controversial FDA Approval for First DMD Drug

    https://www.raps.org/regulatory-foc...controversial-fda-approval-for-first-dmd-drug

    Screen Shot 2020-09-30 at 10.12.32 pm.png

    Surprise approval for Portola’s blood thinner has biotech eyeing a new dawn at the FDA

    https://www.statnews.com/2017/06/23/portola-fda-approval/

    Screen Shot 2020-09-30 at 10.14.35 pm.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
0.015(1.52%)
Mkt cap ! $1.107B
Open High Low Value Volume
$1.01 $1.01 94.3¢ $8.289M 8.492M

Buyers (Bids)

No. Vol. Price($)
1 3 $1.11
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 36 1
View Market Depth
Last trade - 15.59pm 01/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.